|
Product class:
|
Medicinal product with marketing authorization
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Name of medicinal product:
|
Apoquel
|
|
Active substances:
|
|
|
ATC code:
|
QD11AH90
|
|
Dosage form:
|
film-coated tablet
|
|
Strength:
|
3,6mg
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Summary of product characteristics (SPC):
|
|
|
Package information leaflet (PIL):
|
EST
|
|
Labelling:
|
|
|
Indication:
|
Treatment of pruritus associated with allergic dermatitis in dogs.
Treatment of clinical manifestations of atopic dermatitis in dogs.
|
|
Safety features:
|
No
|
|
Marketing authorization holder:
|
Zoetis Belgium
|
|
Marketing authorization number:
|
EU/2/13/154
|
|
Marketing authorization issued on:
|
September 12, 2013
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
Centralised
|
|
Assessment report:
|
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
|
1627815
|
Apoquel
|
film-coated tablet
|
3,6mg 20TK
|
Prescription
|
|
|
28.08.2023
|
|
|
|
1627826
|
Apoquel
|
film-coated tablet
|
3,6mg 100TK
|
Prescription
|
|
|
31.08.2022
|
|
|
|
1668539
|
Apoquel
|
film-coated tablet
|
3,6mg 50TK
|
Prescription
|
|
|
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere